VS-505(AP301)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VS-505(AP301), covering 2022-10-18 to 2022-10-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients [Phase 2]